Register
Log In
My Lectures
My Profile
Log Out

Transforming Healthcare by Staying One Step Ahead

Publication Date: 26 February 2026

Continuing Education Credits: P.A.C.E. NOT AVAILABLE | CPD 0.28.22

Course Description

In this lecture by Dr. Mary Rodgers, it’s critical that we stay one step ahead of infectious disease threats as known viruses evolve and new pathogens emerge faster than ever before. Abbott has expanded on decades of viral surveillance for HIV and hepatitis to identify, track, and respond more quickly to these threats through the Abbott Pandemic Defense Coalition. Join us to learn more about this first-of-its-kind global network that is dedicated to ending current epidemics and helping to prevent future pandemics, and the impact we’ve had in helping provide the healthcare community confidence for today and protection and tomorrow.

Course Objectives
  • Describe the widespread genetic diversity of the HIV virus
  • Explain the historical developments in infectious disease testing over the last 50 years
  • Outline the efforts of Abbott’s Global Viral Surveillance Program to monitor changes in HIV, Hepatitis and other known infectious disease viruses
  • Outline the efforts of the Abbott Pandemic Defense Coalition to detect and respond to infectious disease outbreaks

Run Time: 28:22

Course Instructor Bio(s)

Mary Rodgers, PhD

Associate Research Fellow
Abbott Laboratories
North Chicago, IL

Dr. Mary Rodgers is an Associate Research Fellow in Abbott’s diagnostics business, managing the Abbott Pandemic Defense Coalition, a global network monitoring emerging pathogens to help quickly detect infectious disease outbreaks.    Mary also tracks the diversity of infectious diseases including HIV and hepatitis. In 2019, Mary and a team of Abbott scientists announced the discovery of a new subtype of HIV, marking the first time in 19 years that a new subtype of HIV-1 Group M had been identified.   Mary joined Abbott in 2014, has been part of more than 40 research papers and contributed thousands of viral genomes to public databases. Mary was named one of Business Insider’s 30 under 40 Young Leaders in Biotech in 2017. Mary received her Ph.D. in biological and biomedical sciences from Harvard University and completed her postdoctoral fellowship at the University of Southern California.

Enroll